Abstract:Background: Osteopontin (OPN) is a secreted phosphorylated glycoprotein, which is involved in cell signaling and may promote cell adhesion and migration. Recent studies showed that plasma concentration of OPN was elevated in patients with inflammatory bowel disease (IBD) and it was also expressed in colonic tissue of IBD patients. Aims: To investigate the expression of OPN in colonic tissue of IBD patients and its possible role in the pathogenesis of IBD. Methods: Colonic samples were obtained from patients with ulcerative colitis (UC, n=53), Crohn's disease (CD, n=62) and normal tissue from patients with colonic adenoma (n=15). OPN expression was determined by semi-quantitative immunohistochemical staining. Results: OPN was found to be expressed by intestinal epithelial cells and lamina propria infiltrating cells of colonic tissue. The average optical density values of OPN in intestinal epithelial cells in UC group and CD group were significantly lower than that in control group (11.84±0.98 and 10.04±1.37 vs. 12.64±1.45, P<0.05), while the percentages of lamina propria infiltrating cells expressing OPN in UC group and CD group were significantly higher than that in control group (20.31%± 4.50% and 12.69%±3.06% vs. 3.85%±0.66%, P<0.001). No significant correlations were found between OPN expressions in intestinal epithelial cells and lamina propria infiltrating cells and the disease activities of UC and CD. Conclusions: There is a discrepancy of OPN expression between colonic epithelium mucosae and lamina propria in IBD patients. Downregulation of OPN in intestinal epithelial cells might be related to the disintegration of the intestinal mucosal barrier, while the elevated expression of OPN in lamina propria infiltrating cells might be related to the immune response.

Expression and Its Clinical Significance of Osteopontin in Systemic Lupus Erythematosus with Nephritis

The Expressed Changes and Clinical Significance of Serum Osteopontin in Systemic Lupus Erythematosus Patients

Clinical significance of osteopontin in systemic lupus erythematosus

Detection of osteopontin in sera,urine and renal tissue in patients with systemic lupus erythematosus and its significance

The Relationship Between Osteopontin Plasma Concentration and Disease Activity in Systemic Lupus Erythematosus

A correlation study of serum osteopontin level with disease activity and renal damage in SLE

Therapeutic Effect of Chinese Herbal Medicine for Strengthening Qi, Nourishing Yin, and Removing Stasis on Serum Osteopontin and Quality of Life of Patients with Primary Sjogren'S Syndrome

The Expression and Clinical Relevation of Osteopontin and IL-17 in Severe Hepatitis B

The change of serum osteopontin concentration and synovial membrane expression of osteopontin in patients with rheumatoid arthritis

Decreased Osteopontin Expression as a Reliable Prognostic Indicator of Improvement in Pulmonary Tuberculosis: Impact of the Level of Interferon-x03B3;-Inducible Protein 10.

Decreased Osteopontin Expression as a Reliable Prognostic Indicator of Improvement in Pulmonary Tuberculosis: Impact of the Level of Interferon-γ-Inducible Protein 10

Osteopontin Expression in Oral Lichen Planus

Expression changes of osteopontin in psoriatic lesions of patients with psoriasis vulgaris

Expression of osteopontin in clear cell carcinoma of kidney

Expression of osteopontin in labial salivary glands in patients with Sjogren's syndrome

Expression of osteopontin and other cytokines in serum in Sjogren's syndrome patients

Expression of Osteopontin and Other Cytokines in Saliva and Serum in Patients with Oral Lichen Planus

Expressions of osteopontin and CD68 and their relationship with renal interstitial injury in IgA nephropathy

Expression of osteopontin in non-small cell lung cancer with lymph node metastasis

Expression of Osteopontin in Colonic Tissue of Patients with Inflammatory Bowel Disease

Osteopontin as a Biomarker in Interstitial Lung Diseases